Deaths from Multiple Myeloma


advertisement

Deaths from Multiple Myeloma: 11,016 deaths reported in USA 1999 for multiple myeloma and other immunoproliferative syndromes (NVSR Sep 2001)
Survival rate statistics for Multiple Myeloma: The following are statistics from various sources about the survival rate for Multiple Myeloma:
  • 31% of white people survive 5 years for multiple myeloma in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 33% of African American people survive 5 years for multiple myeloma in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 32% survive 5 years for multiple myeloma in the US 1992-99 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5-year survival rate for black people with multiple myeloma is 29.4% in the US 1983-90 (SEER)
  • 5-year survival rate for people with multiple myeloma is 27.7% in the US 1983-90 (SEER)
  • 5-year survival rate for white people with multiple myeloma is 27.4% in the US 1983-90 (SEER)
  • 1-year survival rate for men aged 15-99 with myeloma is 57.7% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-99 with myeloma is 19.1% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 15-39 with myeloma is 80% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 15-39 with myeloma is 46% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 40-49 with myeloma is 84% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 40-49 with myeloma is 42% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 50-59 with myeloma is 76% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 50-59 with myeloma is 33% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 60-69 with myeloma is 66% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 60-69 with myeloma is 24% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 70-79 with myeloma is 54% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 70-79 with myeloma is 14% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for men aged 80-99 with myeloma is 37% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for men aged 80-99 with myeloma is 8% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-99 with myeloma is 59.3% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-99 with myeloma is 20.5% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 15-39 with myeloma is 88% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 15-39 with myeloma is 49% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 40-49 with myeloma is 75% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 40-49 with myeloma is 40% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 50-59 with myeloma is 78% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 50-59 with myeloma is 36% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 60-69 with myeloma is 66% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 60-69 with myeloma is 23% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 70-79 with myeloma is 57% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 70-79 with myeloma is 17% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 1-year survival rate for women aged 80-99 with myeloma is 38% in England and Wales 1991-95 (Cancer Survival, National Statistics)
  • 5-year survival rate for women aged 80-99 with myeloma is 9% in England and Wales 1991-95 (Cancer Survival, National Statistics)

Death statistics for Multiple Myeloma: The following are statistics from various sources about deaths and Multiple Myeloma:

  • 11,070 estimated deaths for multiple myeloma in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5,430 estimated male deaths for multiple myeloma in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 5,640 estimated female deaths for multiple myeloma in the US 2004 (Cancer Facts and Figures, American Cancer Society, 2004)
  • 670 deaths in men for multiple myeloma in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 580 deaths in women for multiple myeloma in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 3 per 100,000 deaths in women for multiple myeloma in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 4 per 100,000 deaths in men for multiple myeloma in Canada 2004 (Canadian Cancer Statistics, National Cancer Institute of Canada, 2004)
  • 135 annual deaths for multiple myeloma in New Zealand 1999 (New Zealand Health Information, 2002)

Last revision: June 2, 2003

Medical Tools & Articles:


Next articles:

Medical Articles:
 
 
CureResearch.comTM Copyright © 2010 Health Grades, Inc. All rights reserved.
Home | Contents | Search | Site Map | Feedback | Contact Us | Terms of Use | Privacy Policy | About Us | Advertise